CD8A and neoplasm: Conversely, patients with a lack of PD-L1 in TILs were observed to have unobstructed tumor progression, suggesting that PD-L1 blockade neither promotes CD8+ T cell immunity nor prevents effective T cells from infiltrating tumors (11).